EPA:ASMLASML Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ASML Holding NV Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlinesOptions Chain Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ASML. Previous Next 3.9 Community Rank Outperform VotesASML has received 155 “outperform” votes. (Add your “outperform” vote.)Underperform VotesASML has received 44 “underperform” votes. (Add your “underperform” vote.)Community SentimentASML has received 77.89% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ASML and other stocks. Vote “Outperform” if you believe ASML will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ASML will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldASML does not currently pay a dividend.Dividend GrowthASML does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ASML insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.78 out of 5 stars Industry, Sector and Symbol Stock Exchange EPA Industry N/A Sub-IndustryN/A SectorN/A Current SymbolEPA:ASML Previous Symbol CUSIPN/A CIKN/A WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive ASML News and Ratings via Email Sign-up to receive the latest news and ratings for ASML and its competitors with MarketBeat's FREE daily newsletter. ASML (EPA:ASML) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of ASML? 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ASML in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ASML. Has ASML been receiving favorable news coverage? News coverage about ASML stock has trended negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. ASML earned a news impact score of -2.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. View the latest news about ASML. What other stocks do shareholders of ASML own? Based on aggregate information from My MarketBeat watchlists, some companies that other ASML investors own include Abbott Laboratories (ABT), Alibaba Group (BABA), InVitae (NVTA), Applied Materials (AMAT), Amgen (AMGN), American Tower (AMT), Bristol-Myers Squibb (BMY), Boston Scientific (BSX), Citigroup (C) and CBTX (CBTX). What is ASML's stock symbol? ASML trades on the EPA under the ticker symbol "ASML." This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
